Purchase Order W81K0223P0109
Award Date
9/1/23
Potential Completion Date
9/30/27
Potential Value
$341K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $46,030 firm fixed-price purchase order awarded by the Office of Naval Research (ONR), a defense agency, to Qiagen, LLC, a division of the international diagnostics and life sciences company Qiagen N.V. The contract is for the provision of CLC Genomics WB Premium Network products and services, which support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. Qiagen has a history of providing a range of genomics and bioinformatics products and...
This firm fixed-price purchase order was awarded by the Defense Health Agency to Qiagen, LLC, a division of the international provider Qiagen N.V. The $343,500.00 contract is for CLC Genomics Workbench network maintenance services with a completion date of September 27, 2024. Qiagen has provided equipment, software, reagents, and services to support federal biomedical research, public health, law enforcement, and healthcare programs through past prime and subcontracts. This work likely...
This is a $143,604.88 firm-fixed-price definitive contract awarded by the U.S. Army Medical Command (MEDCOM) to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the CLC GENOMICS CLOUD ENGINE, PLUS and has a performance period ending on March 15, 2025. Qiagen is an experienced federal contractor that has provided a range of products and services to support the biomedical research, public health, law enforcement, and healthcare programs of...
The Defense Health Agency awarded a firm-fixed-price purchase order worth $55,002.15 to Qiagen, LLC, a division of the international provider Qiagen N.V., for pathology consultation and laboratory equipment. This award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and sub-contract awards, including DNA/RNA extraction kits,...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and life sciences products. The $211,853.58 contract is for QCII ONE PRECUR 301-600 TESTING and has a performance period ending on May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a substantial portfolio of federal contracts and grants for providing specialized equipment,...
The Department of Agriculture's Animal and Plant Health Inspection Service awarded a $19,052 Firm Fixed Price Purchase Order to Qiagen, LLC, a division of the international company Qiagen N.V. The contract is for the CLC GENOMICS PREMIUM SUITE and has a completion date of March 31, 2024. Qiagen provides a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs, including DNA/RNA extraction kits, next-generation...
This firm fixed-price purchase order was awarded by the Northeast Area of the U.S. federal government to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $5,500.00, is for the provision of CLC Genomics Workbench software. Qiagen is an experienced provider of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs, including DNA/RNA extraction kits, next-generation...
This is a $573,796.56 firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Qiagen, LLC, a division of Qiagen N.V., for an "IPA W/ADVANCED ANALYTICS LCL SOFTWARE." The contract has an ultimate completion date of July 26, 2021 and was awarded on July 27, 2016. There is no set-aside designation mentioned. Qiagen is an international biotechnology company that provides sample and assay technologies for molecular diagnostics, applied testing, pharma, and...
This federal contract award, valued at $44,765.50, was made by the Defense Health Agency (DHA) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, which has no set-aside designation, is for the provision of QIASEQ FORCE products, which are likely targeted DNA panels and kits. The original solicitation, issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA), sought qualified sources capable of providing these specialized molecular...
This is a firm-fixed price purchase order (W81XWH16P0071) awarded by the Medical Command (MEDCOM) of the U.S. Army to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The contract, valued at $56,706.00, is for the provision of an "IPA W/ ADVANCED ANALYTICS LCL" and has a period of performance ending on January 10, 2019. Qiagen is a well-established federal contractor, holding multiple indefinite delivery vehicles (IDVs) with agencies such as the Army...